ASCO 2018/ Event coverage/ Oncology/ Views & Analysis/ Views and analysis ASCO 2018 – Friday 1st and Saturday 2nd June: Bluebird Bio’s CAR-T shines, plus blood tests for lung cancer Richard Staines ASCO2018, blood cancer, cancer, CAR T, multiple myeloma 0 Comment The American Society of Clinical Oncology (ASCO) has already singled out CAR-T therapies as the most promising advance Share X ASCO 2018 – Friday 1st and Saturday 2nd June: Bluebird Bio’s CAR-T shines, plus blood tests for lung cancer https://pharmaphorum.com/views-analysis-oncology/asco-round-up-bluebird-bios-car-t-plus-lynch-syndrome-screening/